Screening for latent tuberculosis before tumour necrosis factor antagonist therapy.

References 1 Morice AH, Millqvist E, Belvisi MG, et al. Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J 2014; 44: 1132–1148. 2 Pullerits T, Ternesten-Hasséus E, Johansson EL, et al. Capsaicin cough threshold test in diagnostics. Respir Med 2014; 108: 1371–1376. 3 Faruqi S, Thompson R, Wright C, et al. Quantifying chronic cough: objective versus subjective measurements. Respirology 2011; 16: 314–320. 4 Abdulqawi R, Dockry R, Holt K, et al. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet 2014 [In press DOI: 10.1016/S0140-6736(14) 61255-1]. 5 Vertigan AE, Theodoros DG, Gibson PG, et al. Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy. Thorax 2006; 61: 1065–1069. 6 Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet 2012; 380: 1583–1589.